Financial Navigation Study Among Young Adult Blood Cancer Survivors

Not Applicable

Completed

• Conditions: Cancer; Financial Stress; Survivorship
• Interventions: Behavioral: Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.

• Registration Number: NCT05620979
• Lead Sponsor: Tufts Medical Center

Brief Summary

Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview.

Detailed Description

This fully remote, multi-site study will evaluate the role of financial navigators in relieving financial distress in young adults (18-39y) who have completed treatment for blood cancer at least three years ago. Serial Assessments at study entry, 3-months, and 6-months measure financial distress measured using the study's primary outcome measure the Personal Financial Wellness Scale™ (PFW) (see below), hypothesized effect modifiers (emotional distress, self-efficacy, cognitive functioning), as well as care seeking, household finances and insurance characteristics. Randomization will occur following completion of baseline measures (see below for description of study arms). In addition to a formal evaluation of the intervention at 3- and 6-months, an optional interview will occur following the 6-month assessment/navigation intervention period to gain further insight from participants about the acceptability of the intervention. For ethical considerations related to the topic of study, all participants will be provided with the Leukemia \& Lymphoma Society's information specialist hotline.

Study Timeline

• Study Start: 2022-02-14
• Study First Submitted: 2022-10-31
• Study First Submitted QC: 2022-11-11
• Study First Posted: 2022-11-17
• Primary Completion: 2023-11-06
• Study Completion: 2023-11-23
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-18
• Last Update Posted: 2024-11-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

1. Previous diagnosis and treatment of blood cancer (leukemia, lymphoma, myeloma, myelodysplastic syndrome, or myeloproliferative neoplasm)
2. Current age between 18-39 years old
3. Blood cancer diagnosis during childhood (0-17 years of age) or young adulthood (18-36 years of age)
4. At least three years post blood cancer diagnosis
5. Off treatment for blood cancer or on a long-term regimen with an oral anti-cancer medication with stable disease
6. Off treatment for a second cancer (non-blood cancer) or on a stable long-term regimen, such as hormone therapy or hormone replacement therapy
7. Primary residence in United States
8. Able to understand and read the English language

Exclusion Criteria

• On parent or guardian's insurance

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Active Navigation	Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.	Active navigation with the study-based financial navigator scheduling four check-in meetings throughout the study with the participant. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.
Ad Hoc Navigation	Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.	Ad hoc navigation in which participant is provided study-based financial navigator to contact as needed. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.
No study-based Navigation	Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.	No access to a study-based financial navigator, but access to a national hotline through the Leukemia \& Lymphoma Society. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Primary Outcome Measures

Name	Time	Method
Personal Financial Wellness Scale (PFW)	6 months	To evaluate the change in financial distress associated with randomization group assignment from baseline to 6-month follow up as measured by the 8-item Personal Financial Wellness Scale (PFW). The PFW scores range from 1-10 where lower scores indicate greater financial distress.

Secondary Outcome Measures

Name	Time	Method
Health-Related Quality of Life (HrQoL) Measures	6 months	As part of Aim 1, we will explore whether changes in financial distress (baseline to 6-months) are moderated by emotional distress, self-efficacy, and cognitive functioning, as measured by Patient-Reported Measurement Information System (PROMIS) 4-item short forms for emotions distress (depression and anxiety) and self-efficacy, as well as the 4-item cognitive functioning scale from the Quality of Life in Neurological Disorders (Neuro-Qol) battery. For each of these short forms, high scores connote better functioning.

Trial Locations

Locations (5)

Bon Secours Mercy Health System; 🇺🇸 Greenville, South Carolina, United States

Tufts Medical Center; 🇺🇸 Boston, Massachusetts, United States

University of Southern California (USC Norris Comprehensive Cancer Center & LA County Hospital); 🇺🇸 Los Angeles, California, United States

Children's Hospital Los Angeles; 🇺🇸 Los Angeles, California, United States

MD Anderson; 🇺🇸 Houston, Texas, United States